News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Institute of Medicinal Molecular Design, Inc. (IMMD) Announces Completion Of The Phase I Clinical Trial Of IMD-0354 Ointment


9/28/2006 11:36:46 AM

Tokyo Japan - Institute of Medicinal Molecular Design, Inc. (IMMD) today announced that it has successfully completed the phase I clinical trial of topical formulation of IMD-0354, a small molecule compound having been developed by IMMD for treatment of atopic dermatitis, and confirmed its safety profile as a novel drug candidate for further development.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES